Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Side effect management preparation

Chapter 36 Common side effect management Preparation Assessment Management Take-home message References Further reading... [Pg.9]

Phentermine is available as an immediate-release and a sustained-release product. In conjunction with a healthy lifestyle, 30 to 37.5 mg of phentermine is administered once daily, typically before breakfast or 1 to 2 hours following the morning meal. The dosage should be individualized some patients maybe managed adequately at 15 to 18.75 mg daily, whereas a dose of 18.75 mg twice daily may be used to minimize side effects, excluding insomnia. To lessen the risk of insomnia, dosing phentermine in the evening should be avoided. Timed-release preparations of phentermine are not recommended because phentermine s half-life is approximately 20 hours.39... [Pg.1536]

Peptide derivatives, (V), prepared by Okada (5) demonstrated a specific and very high x opioid receptor binding affinity and were used as analgesics in severe pain management without devoid of side effects such as addiction and respiratory depression. [Pg.36]

If atropine is used, clinicians must be aware of the signs and symptoms of atropine toxicity. A similar concern exists when 2% cycfopentolate is used in infents or children. If side effects occm optometrists should be prepared to manage them either through direct intervention or referral to other practitioners. [Pg.76]

The side effects and toxicity of the medication The nurse can prepare to manage side effects and recognize the signs of toxicity. [Pg.34]

A side effect is a physiological response in the patient s body that is not related to the drug s primary action. Some side effects are beneficial while side effects—such as nausea and vomiting—are undesirable. By knowing a drug s possible side effects, the nurse can prepare to manage them before the patient is given the dmg. [Pg.69]

A minor study examined the use of Rowatinex in the management of childhood urolithiasis. Six children aged from 4 months to 5 years were administered varying doses of the preparation from 10 days to 12 weeks. All patients became stone-free with no side effects although a de nite conclusion as to the ef cacy of treatment could not be established due to the small patient number involved (Al-Mosawi, 2005). [Pg.396]


See other pages where Side effect management preparation is mentioned: [Pg.646]    [Pg.354]    [Pg.31]    [Pg.341]    [Pg.72]    [Pg.129]    [Pg.646]    [Pg.67]    [Pg.9]    [Pg.199]    [Pg.514]    [Pg.2672]    [Pg.219]    [Pg.341]    [Pg.187]    [Pg.553]    [Pg.176]    [Pg.229]    [Pg.119]    [Pg.374]    [Pg.409]    [Pg.45]    [Pg.129]    [Pg.79]    [Pg.164]    [Pg.256]    [Pg.741]    [Pg.187]    [Pg.530]    [Pg.82]   


SEARCH



Effective manager

Managing effectively

© 2024 chempedia.info